Comparative in vitro activities of ceftaroline and ceftriaxone against bacterial pathogens associated with respiratory tract infections: results from the AWARE surveillance study.

about

Comparative in vitro activities of ceftaroline and ceftriaxone against bacterial pathogens associated with respiratory tract infections: results from the AWARE surveillance study.

Item

http://www.wikidata.org/entity/Q39455499

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Comparative in vitro activitie ...... the AWARE surveillance study.

@en

Comparative in vitro activitie ...... the AWARE surveillance study.

@nl

type

Item

label

Comparative in vitro activitie ...... the AWARE surveillance study.

@en

Comparative in vitro activitie ...... the AWARE surveillance study.

@nl

prefLabel

Comparative in vitro activitie ...... the AWARE surveillance study.

@en

Comparative in vitro activitie ...... the AWARE surveillance study.

@nl

P1476

Comparative in vitro activitie ...... the AWARE surveillance study.

@en

P2093

D F Sahm

http://www.w3.org/2001/XMLSchema#string

D J Biedenbach

http://www.w3.org/2001/XMLSchema#string

J P Iaconis

http://www.w3.org/2001/XMLSchema#string

P2860

Ceftaroline fosamil versus ceftriaxone for the treatment of community-acquired pneumonia: individual patient data meta-analysis of randomized controlled trials.

Ceftaroline fosamil: a brief clinical review.

Assessment of time to clinical response, a proxy for discharge readiness, among hospitalized patients with community-acquired pneumonia who received either ceftaroline fosamil or ceftriaxone in two phase III FOCUS trials

Ceftaroline in the management of complicated skin and soft tissue infections and community acquired pneumonia.

Large retrospective evaluation of the effectiveness and safety of ceftaroline fosamil therapy.

A critical review on the clinical pharmacokinetics, pharmacodynamics, and clinical trials of ceftaroline.

Antimicrobial activity of ceftaroline tested against drug-resistant subsets of Streptococcus pneumoniae from U.S. medical centers.

Potential of Staphylococcus aureus isolates carrying different PBP2a alleles to develop resistance to ceftaroline.

Antimicrobial activity of ceftaroline tested against bacterial isolates causing respiratory tract and skin and skin structure infections in US medical centers in 2013.

In vitro activity of human-simulated epithelial lining fluid exposures of ceftaroline, ceftriaxone, and vancomycin against methicillin-susceptible and -resistant Staphylococcus aureus.

P304

3459-3464

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JAC/DKW315

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27559120

http://www.w3.org/2001/XMLSchema#string